Biochar incorporation in cementitious materials has been widely studied as a cement or binder replacement, but its use specifically as a very-low-dosage fine-aggregate substitute, expressed directly as a fraction of aggregate mass rather than binder mass, remains largely unexplored. This study addresses that gap by systematically comparing three lignocellulosic biochars, corn-stalk (CB), hemp (HB), and beech-wood (BB), incorporated at 0.5% and 1.0% of fine-aggregate mass in a Portland-composite cement mortar (CEM II/B-M (S-L) 42.5R), evaluating fresh-state, hardened-state, transport, and microstructural (SEM–EDS) properties up to 90 days. Results show that even these very low additions produce measurable, feedstock-dependent effects: CB caused the greatest reduction in fresh flow and density, while BB had the smallest effect on workability but produced the largest increase in entrapped air and capillary absorption (+20.5% at 1%, 28 days), along with numerical reductions in compressive (−9.5%), flexural (−12.2%), and splitting tensile strength (−8.2%) at 90 days; of these, only the compressive-strength reduction was confirmed as statistically significant. Feedstock, rather than dosage alone, governed the magnitude of response, and even the most affected mixture retained ~90% of reference compressive strength. SEM–EDS confirmed biochar–matrix integration and linked microstructural heterogeneity to the observed property trends. These findings establish that sub-1% fine-aggregate-level biochar additions are technically viable, with feedstock selection as the critical design variable.
No takes yet. Share an insight, caveat, or question.
Terzić et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: